Topographic Genotyping for Determining the Diagnosis, Malignant Potential, and Biologic Behavior of Pancreatic Cysts and Related Conditions
Interpace Diagnostics Corporation
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 11,143,657 | Topographic Genotyping for Determining the Diagnosis, Malignant Potential, and Biologic Behavior of Pancreatic Cysts and Related Conditions In force · High confidence | Interpace Diagnostics Corporation | In force | High confidence | ||
| Application 11/255,978 | Topographic genotyping for determining the diagnosis, malignant potential, and biologic behavior of pancreatic cysts and related conditions Abandoned Abandoned Jun 30, 2014 | Interpace Diagnostics Corporation | Abandoned | Abandoned Jun 30, 2014 | not computed | |
| Application 14/305,727 | Topographic Genotyping for Determining the Diagnosis, Malignant Potential, and Biologic Behavior of Pancreatic Cysts and Related Conditions Abandoned Abandoned Apr 14, 2018 | Interpace Diagnostics Corporation | Abandoned | Abandoned Apr 14, 2018 | not computed |
3 of 3 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
1 of these is in force and held by Interpace Diagnostics Corporation.
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.